( 09995.hk) | 32.73 | 10.52 | 0% | 上市时间2020-11-09股价83.20港币涨跌幅-4.70%成交金额2.06亿港币换手率0.43%市值469.65亿港币H股市值173.54亿港币总股本5.64亿H股本2.09亿每手股数500上市至今年化投资收益率3.33%港股通持仓占H股比例56.91% (101.14亿港币2026-07-21) 累计做空占H股比例8.81% (14.01亿港币2026-07-17) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.29 | 市净率 | 4.46 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (8): | 双击编辑备注 |
荣昌生物(09995) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 陳雲金 | Independent Non Executive Director | 2022-05-05 | -- | |
| 2 | 馬蘭 | Independent Non Executive Director | 2021-06-01 | -- | |
| 3 | 郝先經 | Independent Non Executive Director - A/F | 2020-05-11 | -- | |
| 4 | 何如意 | Executive Director | 2020-05-11 | -- | |
| 5 | 蘇曉迪 | Non Executive Director | 2020-05-11 | -- | |
| 6 | 王荔強 | Non Executive Director | 2020-05-11 | -- | |
| 7 | 于珊珊 | Independent Non Executive Director - A/F | 2020-05-11 | 2022-05-05 | |
| 8 | BABIUK Lorne Alan | Independent Non Executive Director | 2020-05-11 | 2021-06-01 | |
| 9 | 王威東 | Executive Director | Chairman | 2013-10-30 | -- |
| 10 | 房健民 | Executive Director | CEO | 2008-10-16 | -- |
| 11 | 林健 | Executive Director | 2008-07-04 | -- |